Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05174650
Title Treatment of Atezolizumab and Derazantinib in Patients With Advanced iCCA With FGFR2 Fusions/Rearrangements
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Institut fur Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
HELIOS KLinikum Bad Saarow Bad Saarow Germany Details
MVZ am Oskar-Helene Heim Berlin Berlin Germany Details
Universitätsmedizin Berlin Charité Berlin Germany Details
Vivantes Klinikum Berlin Friedrichshain Berlin Germany Details
Johanniter Krankenhaus Bonn Bonn Germany Details
Uniklinikum Köln Cologne Germany Details
Klinikum Esslingen Esslingen Germany Details
Krankenhaus Nordwest gGmbH Frankfurt Germany Details
Medizinische Hochschule Hannover Hannover Germany Details
Alexianer Krefeld GmbH Krefeld Germany Details
Universitätsklinikum Leipzig Leipzig Germany Details
Universitätsmedizin Mainz Mainz Germany Details
Universitätsmedizin Mannheim Mannheim Germany Details
LMU München Großhadern Munich Germany Details
Klinikum rechts der Isar, Technische Universität München München Germany Details
Universitätsklinikum Tübingen Tübingen Germany Details
Marienhospital Wesel Wesel Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field